Is There Evidence for Late Cognitive Decline in Chronic Schizophrenia? (Q22252612)

7 February 2023

Salah U. Qureshi

series ordinal

2

author given names

Salah U.

author last names

Qureshi

1 reference

7 February 2023

Ali Jawaid

series ordinal

3

author given names

Ali

author last names

Jawaid

1 reference

7 February 2023

Paul E. Schulz

series ordinal

4

author given names

Paul E.

author last names

Schulz

1 reference

https://scigraph.springernature.com/pub.10.1007/s11126-011-9189-8

7 February 2023

language of work or name

English

0 references

publication date

24 August 2011

0 references

published in

Psychiatric Quarterly

0 references

volume

83

0 references

issue

2

0 references

page(s)

127-144

0 references

exact match

0 references

cites work

Neurocognitive impairments in schizophrenia: a piece of the epigenetic puzzle

1 reference

https://api.crossref.org/works/10.1007%2FS11126-011-9189-8

Catamnestic long-term study on the course of life and aging of schizophrenics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11126-011-9189-8

Dementia as a complication of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11126-011-9189-8

Cognitive functions and psychopathological symptoms in early-onset schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11126-011-9189-8

Course of schizophrenia: neuropsychological evidence for a static encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11126-011-9189-8

Is schizophrenia a neurodegenerative disorder? A clinical and neurobiological perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11126-011-9189-8

Cognitive reserve, age, and neuropsychological performance in healthy participants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11126-011-9189-8

Which comes first: atypical antipsychotic treatment or cardiometabolic risk?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11126-011-9189-8

An increased risk of stroke among young schizophrenia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11126-011-9189-8

Traumatic brain injury and schizophrenia in members of schizophrenia and bipolar disorder pedigrees.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11126-011-9189-8

Increased levels of apolipoprotein E in the frontal cortex of subjects with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11126-011-9189-8

Apolipoprotein E in schizophrenia: a French association study and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11126-011-9189-8

Possible effect of the APOE epsilon 4 allele on the hippocampal volume and asymmetry in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11126-011-9189-8

Medical comorbidity in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11126-011-9189-8

Cognitive decline in schizophrenics with Alzheimer's disease: a mini-review of neuropsychological and neuropathological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11126-011-9189-8

Application of cognitive scales to medical records of schizophrenia inpatients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11126-011-9189-8

Six-year follow-up study of cognitive and functional status across the lifespan in schizophrenia: a comparison with Alzheimer's disease and normal aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11126-011-9189-8

Longitudinal assessment of psychopathological domains over late-stage schizophrenia in relation to duration of initially untreated psychosis: 3-year prospective study in a long-term inpatient population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11126-011-9189-8

Three dimensions of clinical symptoms in elderly patients with schizophrenia: prediction of six-year cognitive and functional status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11126-011-9189-8

Long-term outcomes in chronically hospitalized geriatric patients with schizophrenia: retrospective comparison of first generation and second generation antipsychotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11126-011-9189-8

An evaluation of longitudinal neurocognitive performance among middle-aged and older schizophrenia patients: use of mixed-model analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11126-011-9189-8

The longitudinal stability of cognitive impairment in schizophrenia. Mini-mental state scores at one- and two-year follow-ups in geriatric in-patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11126-011-9189-8

Cognitive impairment and negative symptoms in geriatric chronic schizophrenic patients: a follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11126-011-9189-8

The longitudinal relationship of clinical symptoms, cognitive functioning, and adaptive life in geriatric schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11126-011-9189-8

Absence of dementia in late-onset schizophrenia: a one year follow-up of a Brazilian case series.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11126-011-9189-8

Stability and course of neuropsychological deficits in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11126-011-9189-8

Age disorientation in chronic schizophrenia is associated with global intellectual impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11126-011-9189-8

Negative symptoms, neurological signs and neuropsychological impairments in 204 Hong Kong Chinese patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11126-011-9189-8

Long-term outcome of late-onset schizophrenia: 5-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11126-011-9189-8

Effects of neuroleptic medications on the cognition of patients with schizophrenia: a review of recent studies

21 January 2018

1 reference

12 December 2020

Correlates of cognitive impairment in first episode schizophrenia: the EUFEST study

1 reference

12 December 2020

Cognitive dysfunction, negative symptoms, and tardive dyskinesia in schizophrenia. Their association in relation to topography of involuntary movements and criterion of their abnormality

1 reference

12 December 2020

Should cognitive deficit be a diagnostic criterion for schizophrenia?

1 reference

12 December 2020

Relation of neuroleptic and anticholinergic medication to cognitive functions in schizophrenia

1 reference

12 December 2020

Cognitive decline in late-life schizophrenia: a longitudinal study of geriatric chronically hospitalized patients

1 reference

12 December 2020

Long-Term Follow-up and Phenomenologic Differences Distinguish Among Late-Onset Schizophrenia, Late-Life Depression, and Progressive Dementia

1 reference

12 December 2020

Correlates of change in functional status of institutionalized geriatric schizophrenic patients: focus on medical comorbidity

1 reference

12 December 2020

Characterizing coronary heart disease risk in chronic schizophrenia: high prevalence of the metabolic syndrome

1 reference

12 December 2020

Are late-onset schizophrenia spectrum disorders neurodegenerative conditions? Annual rates of change on two dementia measures

1 reference

12 December 2020

Convergence of cognitive and adaptive decline in late-life schizophrenia

1 reference

12 December 2020

Late and very-late first-contact schizophrenia and the risk of dementia-a nationwide register based study

1 reference

12 December 2020

Long-term course of cognitive impairment in schizophrenia

1 reference

12 December 2020

Education and change in cognitive function. The Epidemiologic Catchment Area Study

1 reference

12 December 2020

Neuropsychological correlates of syndromes in schizophrenia

1 reference

12 December 2020

The Course of Functional Decline in Geriatric Patients With Schizophrenia: Cognitive-Functional and Clinical Symptoms as Determinants of Change

1 reference

12 December 2020

Cognitive dysfunction in chronic schizophrenia followed prospectively over 10 years and its longitudinal relationship to the emergence of tardive dyskinesia

1 reference

12 December 2020